Medical innovations and ethics: a state government perspective.
D020811:Biomedical Technology; D003024:Clozapine; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care; D004345:Drug Industry; D004467:Economics; D005380:Financing, Government; D033161:Government Regulation; D015276:Health Care Rationing; D006801:Humans; D016365:Liability, Legal; D008484:Medicaid; D009014:Morals; D009518:New York; D010330:Patents as Topic; D011619:Psychotropic Drugs; D011640:Public Policy; D019057:Quality-Adjusted Life Years; D040841:Resource Allocation; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D013219:State Government; D013673:Technology Assessment, Biomedical; D014481:United States
Health Care and Public Health; Legal Approach; Medicaid; Professional Patient Relationship; Sandoz Pharmaceuticals Corp.